Year-end Sale % OFF 
Abstract
ObjectivesSubstantial rise in the annual incidence of methicillin-resistant Staphylococcus aureus (MRSA) was reported in Southwest Finland (12.4 to 24.9/100 000 people) between 2007–2016. To understand the implications of these changes to the management of MRSA, we sought to analyze the antimicrobial resistance (AMR) trends of MRSA in relation with patient characteristics. MethodsAntimicrobial susceptibility was determined for ten clinically relevant antimicrobials. Strains with resistance to ≥2 antimicrobials were defined multi-resistant. The isolates were spa typed and clustered. AMR trends and risk factors were identified by associating resistant phenotypes with patient demographics. ResultsA total of 983 new MRSA cases were identified between 2007–2016. After 2011, significant increasing trends were observed in the proportion of isolates resistant to clindamycin (13.9 to 31.5%, p<0.001), erythromycin (19.4 to 35.4%, p<0.001) and tetracycline (16.7 to 32%, p<0.001). The proportion of multi-resistant isolates more than doubled from 14.8 to 39.2%. The increasing AMR trend was reflected in the increase of new strain types and the decrease of previously dominant, non-multi-resistant strains. Patient risk factors associated with (p<0.001) the acquisition of multi-resistant strains included community acquisition, livestock contact, hospital care abroad and immigrant status. ConclusionsNotable increasing AMR trends among MRSA isolates were observed in Southwest Finland, 2007–2016. The shift in patient demographics to younger age groups and community acquisition contributed to the increase in multi-resistant strains. Immigration, contact with hospital environment abroad and contact with livestock were identified as essential risk factors of multi-resistance. The increased level of co-resistance has persisted after 2016.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
